34732147|t|A new side-effect of sufentanil: increased monocyte-endothelial adhesion.
34732147|a|BACKGROUND: Opioids have been identified by the World Health Organization to be 'indispensable for the relief of pain and suffering'. Side-effects, such as nausea, vomiting, postoperative delirium, and effects on breathing, of opioids have been well investigated; however, the influence of opioids on monocyte-endothelial adherence has never been reported. Therefore, we explored the effects of representative opioids, fentanyl, sufentanil, and remifentanil, on monocyte-endothelial adherence and the underlying mechanisms. METHODS: We built a cell adhesion model with U937 monocytes and human umbilical vein endothelial cells (HUVECs). Two kinds of connexin43 (Cx43) channel inhibitors, 18-alpha-GA and Gap 27, were used to alter Cx43 channel function in U937 monocytes and HUVECs, respectively, to determine the effects of Cx43 channels on U937-HUVEC adhesion. Subsequently, the effects of fentanyl, sufentanil and remifentanil on Cx43 channel function and U937-HUVEC adhesion were explored. RESULTS: When fentanyl, sufentanil and remifentanil acted on monocytes or endothelial cells, their effects on monocyte-endothelial adherence differed. When acting on U937 monocytes, sufentanil significantly increased U937-HUVEC adhesion which was associated with reduced release of ATP from Cx43 channels, while fentanyl and remifentanil did not have these influences. Although sufentanil could also inhibit Cx43 channel function in HUVECs, it had no effect on ATP release from HUVECs or U937-HUVECs adhesion. CONCLUSIONS: We demonstrated that sufentanil application increases monocyte-endothelial adherence which was associated with reduced release of ATP from Cx43 channels in monocytes. This side-effect of sufentanil should be considered seriously by clinicians.
34732147	21	31	sufentanil	Chemical	MESH:D017409
34732147	187	191	pain	Disease	MESH:D010146
34732147	230	236	nausea	Disease	MESH:D009325
34732147	238	246	vomiting	Disease	MESH:D014839
34732147	248	270	postoperative delirium	Disease	MESH:D000071257
34732147	493	501	fentanyl	Chemical	MESH:D005283
34732147	503	513	sufentanil	Chemical	MESH:D017409
34732147	519	531	remifentanil	Chemical	MESH:D000077208
34732147	643	647	U937	CellLine	CVCL:0007
34732147	662	667	human	Species	9606
34732147	724	734	connexin43	Gene	2697
34732147	736	740	Cx43	Gene	2697
34732147	762	773	18-alpha-GA	Chemical	MESH:C119129
34732147	778	784	Gap 27	Chemical	-
34732147	805	809	Cx43	Gene	2697
34732147	830	834	U937	CellLine	CVCL:0007
34732147	899	903	Cx43	Gene	2697
34732147	916	920	U937	CellLine	CVCL:0007
34732147	966	974	fentanyl	Chemical	MESH:D005283
34732147	976	986	sufentanil	Chemical	MESH:D017409
34732147	991	1003	remifentanil	Chemical	MESH:D000077208
34732147	1007	1011	Cx43	Gene	2697
34732147	1033	1037	U937	CellLine	CVCL:0007
34732147	1082	1090	fentanyl	Chemical	MESH:D005283
34732147	1092	1102	sufentanil	Chemical	MESH:D017409
34732147	1107	1119	remifentanil	Chemical	MESH:D000077208
34732147	1234	1238	U937	CellLine	CVCL:0007
34732147	1250	1260	sufentanil	Chemical	MESH:D017409
34732147	1285	1289	U937	CellLine	CVCL:0007
34732147	1350	1353	ATP	Chemical	MESH:D000255
34732147	1359	1363	Cx43	Gene	2697
34732147	1380	1388	fentanyl	Chemical	MESH:D005283
34732147	1393	1405	remifentanil	Chemical	MESH:D000077208
34732147	1446	1456	sufentanil	Chemical	MESH:D017409
34732147	1476	1480	Cx43	Gene	2697
34732147	1529	1532	ATP	Chemical	MESH:D000255
34732147	1556	1560	U937	CellLine	CVCL:0007
34732147	1612	1622	sufentanil	Chemical	MESH:D017409
34732147	1721	1724	ATP	Chemical	MESH:D000255
34732147	1730	1734	Cx43	Gene	2697
34732147	1778	1788	sufentanil	Chemical	MESH:D017409
34732147	Negative_Correlation	MESH:D017409	2697
34732147	Negative_Correlation	MESH:C119129	2697
34732147	Comparison	MESH:D000077208	MESH:D017409
34732147	Negative_Correlation	MESH:D000255	MESH:D017409
34732147	Association	MESH:D000255	2697
34732147	Positive_Correlation	MESH:D017409	MESH:D014839

